U.S. drugmakers' push boosts sales of drugs for 'murky' ailment

WASHINGTON - Two drugmakers spent hundreds of millions of dollars last year to raise awareness of a murky illness, helping boost sales of pills recently approved as treatments and drowning out unresolved questions - including whether it's a real disease at all....More